Anxo Pharmaceutical Co., Ltd. (TPEX:6677)
Taiwan
· Delayed Price · Currency is TWD 18.05
+0.15 (0.84%)
Apr 24, 2025, 12:53 PM CST
Anxo Pharmaceutical Revenue
In the year 2024, Anxo Pharmaceutical had annual revenue of 895.32M TWD, down -4.75%. Anxo Pharmaceutical had revenue of 480.44M in the half year ending December 31, 2024, a decrease of -3.15%.
Revenue
895.32M
Revenue Growth
-4.75%
P/S Ratio
1.13
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.01B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 895.32M | -44.62M | -4.75% |
| Dec 31, 2023 | 939.94M | 73.67M | 8.50% |
| Dec 31, 2022 | 866.27M | 42.17M | 5.12% |
| Dec 31, 2021 | 824.10M | -42.01M | -4.85% |
| Dec 31, 2020 | 866.11M | -11.82M | -1.35% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 9.73B |
| Caliway Biopharmaceuticals | 44.43M |
| Bora Pharmaceuticals Co., LTD. | 19.25B |
| Lotus Pharmaceutical | 18.58B |
| Polaris Group | 107.00M |
| Oneness Biotech | 117.93M |
| Pegavision | 6.82B |
| Lumosa Therapeutics | 39.15M |